IDD Fellowship: Academics
Fellows will learn the clinical management of patients with advanced malignancies receiving treatment on Phase I clinical trials. This will include documentation necessary for clinical research subjects, the ethical aspects and regulatory process of informed consent as well as the capture of data including understanding the common toxicity criteria used in toxicity assessment.
- Gain insights into clinical trial protocol writing and regulatory approval
- Attend and present at several regularly scheduled conferences and research meetings
- Spend time in a variety of laboratories at either UT Health San Antonio, UTSA or UT Austin to gain exposure to different aspects of drug discovery or development.
- Participate in 2.5 days/week of research clinics. At least one of these clinic days will be spent evaluating new patient referrals for clinical trials under the supervision of licensed clinical research staff physicians.
Fellows will continue to be involved with the clinical research and projects from year 1. In addition each fellow will run and initiate an entire study until completion of their program, under the supervision of staff. This will incorporate patient selection, data management, necessary decisions related to protocol adherence as well as necessary changes and amendments to improve feasibility as well as patient safety.
- Serve as co-principal investigators on several other studies and as a sub-investigator on colleagues’ protocols.
- You will be encouraged to design and initiate an Investigator Sponsored study.
- Learn the basics of data analysis and pharmacokinetics and incorporate this knowledge into the execution of each study.
- Attend several regularly scheduled conferences and research meetings.
- For those who express interest, more dedicated time to work in a drug discovery/development laboratory will be made available.
- Assume responsibility for walk-in patients on a rotating basis, and be responsible for this activity for 2-3 months each year.
- You will be given “protected time” for at least 2.5 days each week to pursue individual research projects.
- Analyze the data gained from the protocols that have been successfully executed as well as the studies participated in. Furthermore detailed pharmacokinetic and pharmacodynamic analysis of the results will enable the fellow to fully satisfy the scientific nature of the study and assist in a further understanding of the experimental agent examined.
- Produce a manuscript that ultimately will be submitted for peer-reviewed publication, and publish at least 1-2 manuscripts that detail projects worked on since inception.
- Be able to construct the next steps for both the clinical development of the agent studied as well as learning the essentials of grant writing for further career development.